China Botanic Q3 net sales rise 33.6%
The rise was mainly attributable to year-over-year increase in average selling prices of the company’s products and the growing market acceptance of the Company’s new products introduced in
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.